Treatment of Acanthamoeba keratitis: Standard, problems, and new approaches;Die Behandlung der Acanthamoeba-Keratitis: Möglichkeiten, Probleme und neue Wege

Wiener Klinische Wochenschrift, Supplement

Volumn 115, Issue 3, 2003, Pages 10-17

  Walochnik, Julia ^a   Duchêne, Michael ^b   Eibl, Hansjörg ^c   Aspöck, Horst ^a  

^a Abt fur Medizinische Parasitologie   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

Acanthamoeba; Acanthamoeba keratitis; Alkylphosphocholines; Contact lenses; Therapy

Indexed keywords

ALEXIDINE; AZITHROMYCIN; CHLORHEXIDINE; CLOTRIMAZOLE; DIBROMPROPAMIDINE; DIMETHYL SULFOXIDE; DIMINAZENE ACETURATE; HEXAMIDINE; HEXAMIDINE ISETIONATE; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; MILTEFOSINE; MYRISTAMIDOPROPYL DIMETHYLAMINE; NEOMYCIN; PAROMOMYCIN; PENTAMIDINE ISETHIONATE; PHENOTHIAZINE DERIVATIVE; PHOSPHORYLCHOLINE; POLY(HEXAMETHYLENEBIGUANIDE); POVIDONE IODINE; PROPAMIDINE; PROPAMIDINE ISETHIONATE; UNCLASSIFIED DRUG;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; ANTINEOPLASTIC ACTIVITY; CONFERENCE PAPER; CONTACT LENS; CYTOTOXICITY; DRUG DOSE REGIMEN; DRUG RESISTANCE; ENTAMOEBA HISTOLYTICA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA DONOVANI; PATIENT COMPLIANCE; PENETRATING KERATOPLASTY; TRYPANOSOMA CRUZI; VISUAL IMPAIRMENT;

ACANTHAMOEBA KERATITIS; ANTIPROTOZOAL AGENTS; BENZAMIDINES; BIGUANIDES; CONTACT LENS SOLUTIONS; CONTACT LENSES; DRUG COMBINATIONS; HUMANS; PATIENT COMPLIANCE; PHOSPHORYLCHOLINE; TREATMENT OUTCOME;

EID: 0842291589     PISSN: 03005178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (64)

1. Martinez AJ, Visvesvara GS (1997) Free-living, amphizoic and opportunistic amebas. Brain Pathol 7: 583-598
2. Nagington F, Watson PG, Playfair TJ, McGill J, Hones BR, Steele ADM (1974) Amoebic infection of the eye. Lancet 2: 1537-1540
3. Moore MB, McCulley JP, Luckenbach M, Gelender H, Newton C, McDonald MB, et al (1985) Acanthamoeba keratitis associated with soft contact lenses. Am J Ophthalmol 100: 396-403
4. Bacon AS, Frazer DG, Dart JK, Matheson M, Ficker LA, Wright P (1993) A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye 7: 719-725
5. Bernauer W, Duguid GI, Dart JK (1996) Early clinical diagnosis of Acanthamoeba keratitis. A study of 70 eyes. Klin Monatsbl Augenheilkd 208: 282-284
6. Radford CF, Lehmann OJ, Dart JKG (1998) Acanthamoeba keratitis: multicentre survey in England 1992-6. Br J Ophthalmol 82: 1387-1392
7. Claerhout I, Kestelyn P (1999) Acanthamoeba keratitis: a review. Bull Soc Belge Ophtalmol 274: 71-82
8. Cohen E, Fulton J, Hoffman C, Rapuano C, Laibson P (1996) Trends in contact lens-associated corneal ulcers. Cornea 15: 566-570
9. Lam DS, Houang E, Fan DS, Lyon D, Seal D, Wong E (2002) Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. Eye 16: 608-618
10. Sharma S, Garg P, Rao GN (2000) Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol 84: 1103-1108
11. Kunimoto DY, Sharma S, Garg P, Gopinathan U, Miller D, Rao GN (2000) Corneal ulceration in the elderly in Hyderabad, south India. Br J Ophthalmol 84: 54-59
12. Kumar R, Lloyd D (2002) Recent advances in the treatment of Acanthamoeba keratitis. Clin Infect Dis 35: 434-341
13. Radford CF, Minassian DC, Dart JK (2002) Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol 86: 536-542
14. Schaumberg DA, Snow KK, Dana MR (1998) The epidemic of Acanthamoeba keratitis: Where do we stand? Cornea 17: 3-10
15. Stothard DR, Schroeder-Dietrich JM, Awwad MH, Gast RJ, Ledee DR, Rodriguez-Zaragoza S, et al (1998) The evolutionary history of the genus Acanthamoeba and the identification of eight new 18S rDNA gene sequence types. J Euk Microbiol 45: 45-54
16. Walochnik J, Haller-Schober E, Kolli H, Picher O, Obwaller A, Aspöck H (2000) Discrimination between clinically relevant and nonrelevant Acanthamoeba strains isolated from contact lens-wearing keratitis patients in Austria. J Clin Microbiol 38: 3932-3936
17. Larkin DF, Kilvington S, Easty DL (1990) Contamination of contact lens storage cases by Acanthamoeba and bacteria. Br J Ophthalmol 74: 133-135
18. Hiti K, Walochnik J, Faschinger C, Haller-Schober EM, Aspöck H (2001) Microwave treatment of contact lens cases contaminated with Acanthamoeba. Cornea 20: 467-470
19. Hiti K, Walochnik J, Haller-Schober EM, Faschinger C, Aspock H (2002) Viability of Acanthamoeba after exposure to a multipurpose disinfecting contact lens solution and two hydrogen peroxide systems. Br J Ophthalmol 86: 144-146
20. Badenoch PR, Adams M, Coster DJ (1995) Corneal virulence, cytopathic effect on human keratocytes and genetic characterisation of Acanthamoeba. Int J Parasitol 25: 229-239
21. Illingworth CD, Cook SD (1998) Acanthamoeba keratitis. Surv Ophthalmol 42: 493-508
22. Armstrong M (2000) The pathogenesis of human Acanthamoeba infection. Infect Dis Rev 2: 65-73
23. Tabin G, Taylor H, Snibson G, Murchison A, Gushchin A, Rogers S (2001) Atypical presentation of Acanthamoeba keratitis. Cornea 20: 757-959
24. Walochnik J, Picher O, Aspöck C, Ullmann M, Sommer R, Aspöck H (1999) Interactions of "Limax amoebae" and gram-negative bacteria: experimental studies and review of current problems. Tokai J Exp Clin Med 23: 273-278
25. Lee GA, Gray TB, Dart JK, Pavesio CE, Ficker LA, Larkin DF, et al (2002) Acanthamoeba sclerokeratitis: treatment with systemic immunosuppression. Ophthalmology 109: 1178-1182
26. Moshari A, McLean IW, Dodds MT, Damiano RE, McEvoy PL (2001) Chorioretinitis after keratitis caused by Acanthamoeba: case report and review of the literature. Ophthalmology 108: 2232-2236
27. Lim L, Coster DJ, Badenoch PR (2000) Antimicrobial susceptibility of 19 Australian corneal isolates of Acanthamoeba. Clin Experiment Ophthalmol 28: 119-124
28. Turner NA, Russel AD, Furr JR, Lloyd D (2000) Emergence of resistance to biocides during differentiation of Acanthamoeba castellanii. J Antimicrob Chemother 46: 27-34
29. Kilvington S, Anger C (2001) A comparison of cyst age and assay method of the efficacy of contact lens disinfectants against Acanthamoeba. Br J Ophthalmol 85: 336-340
30. Hargrave SL, McCulley JP, Husseini Z (1999) Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Brolene Study Group. Ophthalmology 106: 952-957
31. Wright P, Warhurst D, Jones BR (1985) Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 69: 778-782
32. Larkin DF, Kilvington S, Dart JK (1992) Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 99: 185-191
33. Burger RM, Franco RJ, Drlica K (1994) Killing acanthamoebae with polyaminopropyl biguanide: quantitation and kinetics. Antimicrob Agents Chemother 38: 886-888
34. Duguid IG, Dart JK, Morlet N, Allan BD, Matheson M, Ficker L, et al (1997) Outcome of Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 104: 1587-1592
35. Donoso R, Mura JJ, Lopez M (2002) Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB). Rev Med Chil 130: 396-401
36. Panda A, Das GK, Biswas NR, Mittal D, Mohanty S (2000) Therapy of Acanthamoeba keratitis - an experimental study. Indian J Physiol Pharmacol 44: 363-367
37. Berger ST, Mondino BJ, Hoft RH, Donzis PB, Holland GN, Farley MK, Levenson JE (1990) Successful medical management of Acanthamoeba keratitis. Am J Ophthalmol 110: 395-403
38. Lam DS, Lyon D, Poon AS, Rao SK, Fan DS (2000) Polyhexamethylene biguanide (0.02%) alone is not adequate for treating chronic Acanthameoba keratitis. Eye 14: 678-679
39. Lindquist TD (1998) Treatment of Acanthamoeba keratitis. Cornea 17: 11-16
40. Alizadeh H, Silvany RE, Meyer DR, Dougherty JM, McCulley JP (1997) In vitro amoebicidal activity of propamidine and pentamidine isethionate against Acanthamoeba species and toxicity to corneal tissues. Cornea 16: 94-100
41. Driebe WT Jr, Stern GA, Epstein RJ, Visvesvara GS, Adi M, Komadina T (1988) Acanthamoeba keratitis. Potential role for topical clotrimazole in combination chemotherapy. Arch Ophthalmol 106: 1196-1201
42. Ishibashi Y, Matsumoto Y, Kabata T, Watanabe R, Hommura S, Yasuraoka K, Ishii K (1990) Oral itraconazole and topical miconazole with debridement for Acanthamoeba keratitis. Am J Ophthalmol 109: 121-126
43. Saunders PP, Proctor EM, Rollins DF, Richards JS (1992) Enhanced killing of Acanthamoeba cysts in vitro using dimethylsulfoxide. Ophthalmology 99: 1197-1200
44. O'Day DM, Head WS (2000) Advances in the management of keratomycosis and Acanthamoeba keratitis, Cornea 19: 681-687
45. McClellan K, Howard K, Niederkorn JY, Alizadeh H (2001) Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci 42: 2885-2893
46. Murthy S, Hawksworth NR, Cree I (2002) Progressive ulcerative keratitis related to the use of topical chlorhexidine gluconate (0.02%). Cornea 21: 237-239
47. Kilvington S, Hughes R, Byas J, Dart J (2002) Activities of therapeutic agents and myristamidopropyl dimethylamine against Acanthamoeba isolates. Antimicrob Agents Chemother 46: 2007-2009
48. Kilvington S, Larkin DF, White DG, Beeching JR (1990) Laboratory investigation of Acanthamoeba keratitis. J Clin Microbiol 28: 2722-2725
49. Ficker L, Seal D, Warhurst D, Wright P (1990) Acanthamoeba keratitis-resistance to medical therapy. Eye 4: 835-838
50. Vaquero Ruano M, Encinas Martin JL, Ramon Y Cajal S, Cajigal Morales C (2002) Acanthamoeba keratitis, a possible dibromo propamidine isethionate resistance. Arch Soc Esp Oftalmol 77: 279-282
51. Seal DV, Hay J, Kirkness CM (1995) Chlorhexidine or polyhexamethylene biguanide for Acanthamoeba keratitis. Lancet 345: 136
52. Seal DV, Hay J, Kirkness CM, Morrell A, Booth A, Tullo A, et al (1996) Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye 10: 413-421
53. Borazjani RN, May LL, Noble JA, Avery SV, Ahearn DG (2000) Flow cytometry for determination of the efficacy of contact lens disinfecting solutions against Acanthamoeba spp. Appl Environ Microbiol 66: 1057-1061
54. Kosrirukvongs P, Wanachiwanawin D, Visvesvara GS (1999) Treatment of Acanthamoeba keratitis with chlorhexidine. Ophthalmology 106: 798-802
55. Brasseur G, Favennec L, Perrine D, Chenu JP, Brasseur P (1994) Successful treatment of Acanthamoeba keratitis by hexamidine. Cornea 13: 459-462
56. Gatti S, Cevini C, Bruno A, Penso G, Rama P, Scaglia M (1998) In vitro effectiveness of povidone-iodine on Acanthamoeba isolates from human cornea. Antimicrob Agents Chemother 42: 2232-2234
57. Schuster FL, Visvesvara GS (1998) Efficacy of novel antimicrobials against clinical isolates of opportunistic amebas. J Eukaryot Microbiol 45: 612-618
58. Amoils SP, Heney C (1999) Acanthamoeba keratitis with live isolates treated with cryosurgery and fluconazole. Am J Ophthalmol 127: 718-720
59. Walochnik J, Duchene M, Seifert K, Obwaller A, Hottkowitz T, Wiedermann G, et al (2002) Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp. Antimicrob Agents Chemother 46: 695-701
60. Eibl H, Unger C (1990) Hexadecylphosphocholine: a new and selective antitumor drug. Cancer Treat Rev 17: 233-242
61. Croft SL, Neal RA, Pendergast W, Chan JH (1987) The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani. Biochem Pharmacol 36: 2633-2636
62. Kuhlencord A, Maniera T, Eibl H, Unger C (1992) Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Antimicrob Agents Chemother 36: 1630-1634
63. Santa-Rita RM, Santos Barbosa H, Meirelles MN, de Castro SL (2000) Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruzi. Acta Trop 75: 219-228
64. Seifert K, Duchêne M, Wernsdorfer WH, Kollaritsch H, Scheiner O, Wiedermann G, et al (2001) Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica. Antimicrob Agents Chemother 45: 1505-1510